Importantly, B2M (Beta-2-Microglobulin), essential for expression of MHC class I and thus immunologic targeting of tumor cells by CD8+T cells, was downregulated (log2 T/N < 0) in both LST and HST (Additional file 1: Figure S2d) [30]. The gene discussed is CD8A; the disease is neoplasm.